Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wanish cream is a topical Ayurvedic skincare formulation developed and marketed by Ozone Pharmaceuticals. It is composed of a blend of natural plant extracts and oils, including *Aloe barbadensis* leaf extract (4%), *Centella asiatica* plant extract (3%), *Citrus sinensis* rind extract (1%), *Curcuma longa* rhizome extract (0.05%), sweet almond oil (*Prunus amygdalus* oil, 2%), and wheat germ oil (1%). The cream is designed to address various dermatological concerns such as acne scars, stretch marks, blemishes, dark spots, and hyperpigmentation. It works by deeply moisturizing and rejuvenating dry skin, promoting collagen synthesis to aid skin repair, and providing anti-inflammatory and antioxidant protection. Additionally, it is utilized to soothe skin irritation and manage conditions like dry eczema, dermatitis, and skin rashes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wanish cream.